![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.ema.europa.eu/en/documents/overview/degarelix-accord-epar-medicine-overview_en.pdf
https://www.clinicaltrialsarena.com/news/ucla-degarelix-covid-19-trial/
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-firmagon-22201-degarelix-acetate-80-mgvial-and-120-mgvialpowder-for-injection-1581763881.pdf
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
http://www.fiercebiotech.com/story/ferring-pits-prostate-cancer-drug-against-abbvies-lupron-phiiib-cv-outcomes/2016-02-10
http://www.pharmatimes.com/Article/15-06-05/NICE_backs_Bayer_s_Xofigo_but_rejects_Ferring_s_Firmagon.aspx